Evidence map›Paper›PMID 37013369›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2023

Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension.

Faris Matanes, Mohammed Siddiqui, Alejandro Velasco, Oleg Sharifov, Eric Kreps, Tanja Dudenbostel, Eric K Judd, Bin Zhang, Steven G Lloyd, Suzanne Oparil and 1 more

Abstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Faris MatanesVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.ORCID 0000-0001-6211-6656
Mohammed SiddiquiVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.ORCID 0000-0002-8463-6537
Alejandro VelascoCardiology Department, Montefiore Medical Center, Bronx, New York, USA.
Oleg SharifovDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Eric KrepsDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Tanja DudenbostelVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.
Eric K JuddVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.
Bin ZhangDivision of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Steven G LloydVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.
Suzanne OparilVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.
David A CalhounVascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, USA.

Funding

MECHANISMS OF HYPERTENSION AND CARDIOVASCULAR DISEASEST32HL007457 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Martin E Young · 1985 to 2026
$8.6M
Mechanisms of Refractory HypertensionR01HL113004 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OPARIL, SUZANNE · 2014 to 2018
$2.5M
NHLBI NIH HHS R01 HL113004NHLBI NIH HHS T32 HL007457NIH HHS 5T32HL007457-37NIH HHS NIH R01 HL113004
6 · The paper itself

Abstract

Resistant hypertension (RHTN), defined as blood pressure (BP) that is uncontrolled with ≥3 medications, including a long-acting thiazide diuretic, also includes a subset with BP that is controlled with ≥4 medications, so-called controlled RHTN. This resistance is attributed to intravascular volume excess. Patients with RHTN overall have a higher prevalence of left ventricular hypertrophy (LVH) and diastolic dysfunction compared to patients with non-RHTN. We tested the hypothesis that patients with controlled RHTN due to the intravascular volume excess have higher left ventricular mass index (LVMI), higher prevalence of LVH, larger intracardiac volumes, and more diastolic dysfunction compared to patients with controlled non-resistant hypertension (CHTN), defined as BP controlled with ≤3 anti-hypertensive medications. Patients with controlled RHTN (n = 69) or CHTN (n = 63) who were treated at the University of Alabama at Birmingham were offered enrollment and underwent cardiac magnetic resonance imaging. Diastolic function was assessed by peak filling rate, time needed in diastole to recover 80% of stroke volume, E:A ratios and left atrial volume. LVMI was higher in patients with controlled RHTN (64.4 ± 22.5 vs 56.9 ± 11.5; P = .017). Intracardiac volumes were similar in both groups. Diastolic function parameters were not significantly different between groups. There were no significant differences in age, gender, race, body mass index, dyslipidemia between the two groups. The findings show that patients with controlled RHTN have higher LVMI, but comparable diastolic function to those of patients with CHTN.

Indexed as

Heart FailureHypertensionAntihypertensive AgentsBlood PressureDiastoleHeart AtriaHumansHypertrophy, Left VentricularVentricular RemodelingAntihypertensive Agentscardiac remodelingdiastolic functionleft ventricular massmasked uncontrolled hypertensionresistant hypertension

Identifiers

PMID37013369
PMCPMC10184488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.